0001551986-23-000041.txt : 20230519 0001551986-23-000041.hdr.sgml : 20230519 20230519080259 ACCESSION NUMBER: 0001551986-23-000041 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230518 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 9 METERS BIOPHARMA, INC. CENTRAL INDEX KEY: 0001551986 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273948465 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37797 FILM NUMBER: 23937938 BUSINESS ADDRESS: STREET 1: 4509 CREEDMOOR ROAD STREET 2: SUITE 600 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919-275-1933 MAIL ADDRESS: STREET 1: 4509 CREEDMOOR ROAD STREET 2: SUITE 600 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Monster Digital, Inc. DATE OF NAME CHANGE: 20150930 FORMER COMPANY: FORMER CONFORMED NAME: Tandon Digital, Inc. DATE OF NAME CHANGE: 20120611 8-K 1 nmtr-20230518.htm 8-K nmtr-20230518
0001551986FALSE00015519862023-05-182023-05-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
FORM 8-K
 
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): May 18, 2023
 
 
 
9 Meters Biopharma, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware 001-37797 27-3948465
(State or other jurisdiction of
incorporation or organization)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
 
4509 Creedmoor Road, Suite 600, Raleigh, NC 27612
(Address of principal executive offices) (Zip Code)
 
(919) 275-1933
(Registrant’s telephone number, include area code)
 

(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock $0.0001 Par ValueNMTRThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 



Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 1.01.Entry Into a Material Definitive Agreement.
As previously disclosed in the Current Report on Form 8-K filed on April 27, 2023 by 9 Meters Biopharma, Inc. (the “Company”), on April 26, 2023, the Company entered into a forbearance agreement (the “Forbearance Agreement”) with the holder (the “Holder”) of the Company’s amended and restated senior secured convertible note, originally issued on July 15, 2022, which was subsequently amended and restated on November 7, 2022, and further amended on January 12, 2023 (the “Note”). On May 18, 2023, the Holder and the Company agreed to amend the Forbearance Agreement (the “Amendment”) to (a) release $527,792.78 to the Company from the reserve account and reduce the restricted amount required to be held in such account under the terms of the Note to $1,075,000 and (b) extend the term of the Forbearance Agreement to the earliest of (i) May 29, 2023 or such later date agreed to by the Holder in writing, (ii) the occurrence of a default (other than the existing default) under the Note or related Note transaction documents, (iii) the Company receives notice from Nasdaq that its compliance plan is not accepted, or the Company’s common stock is delisted or halted from trading for more than one trading day, or (iv) the occurrence of a breach by the Company or its subsidiary of any of the representations, warranties, agreements or covenants.

Except as set forth above, all other terms, conditions and rights of the Forbearance Agreement, the Note and the related Note transaction documents remain in full force and effect, which were described in the Current Report on Form 8-K filed by the Company on June 30, 2022, the Quarterly Report on Form 10-Q filed by the Company on November 8, 2022, the Current Report on Form 8-K filed by the Company on January 13, 2023, and the Current Report on Form 8-K on April 27, 2023.

The foregoing description of the Amendment does not purport to be complete and is subject to, and qualified by, the full text of such document, a copy of which is filed as Exhibit 10.1 and is incorporated by reference herein.

Item 2.04.
Triggering Events that Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.

To the extent applicable, the information related to the Amendment set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 9.01.Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.Description
Exhibit 10.1
Exhibit 104Cover Page Interactive Data File (embedded within the Inline XBRL document).






SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
    
 9 Meters Biopharma, Inc.
    
Date: May 19, 2023By: /s/ Bethany Sensenig
   Bethany Sensenig
   Chief Financial Officer
 
 
 
 

 

 
 
 


EX-10.1 2 ex-101forbearanceagmt523.htm EX-10.1 Document
EX-10.1
AMENDMENT NO. 1 TO FORBEARANCE AGREEMENT

THIS AMENDMENT NO. 1 TO FORBEARANCE AGREEMENT (this “Amendment”) is entered into as of May 18, 2023 by and among HIGH TRAIL SPECIAL SITUATIONS LLC, a Delaware limited liability company (in its capacity as holder, secured party or collateral agent, as applicable, “Purchaser”), 9 Meters Biopharma, Inc., a Delaware corporation (“Issuer”), and Naia Rare Diseases, LLC, a Delaware limited liability company (“Guarantor” and, together with Issuer, the “Note Parties”).

WITNESSETH:

WHEREAS, the Parties are party to that certain Forbearance Agreement, dated as of April 26, 2023 (as amended hereby, the “Forbearance Agreement”);
WHEREAS, the Note Parties have requested to amend the Forbearance Agreement as set forth herein, and Purchaser has agreed to such amendment, upon the terms and subject to the conditions set forth herein;
NOW, THEREFORE, in consideration of the foregoing premises, and other good and valuable consideration, the receipt and legal sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
AGREEMENT:

1.Recitals. The foregoing recitals are confirmed as true and correct and are incorporated herein by reference. The recitals are a substantive, contractual part of this Amendment.
2.Definitions. Capitalized terms appearing herein and not otherwise defined shall have the meanings ascribed to such terms in the Forbearance Agreement and the other Note Documents, as applicable, unless the context hereof shall otherwise require or provide.
3.Amendments to Forbearance Agreement. Subject to the conditions precedent set forth in Section 6 herein and reliance on the representations and warranties set forth in Section 7 herein, the Forbearance Agreement is hereby amended as follows:
(a)Section 6(a) of the Forbearance Agreement is hereby amended by replacing the reference to “May 16, 2023” in clause (i) thereof with “May 29, 2023, or such later date agreed to by Purchaser in writing”.
(b)Section 7(d) of the Forbearance Agreement is hereby deleted and replaced in its entirety with the following:
“7(d) The Securities Account of Issuer with Wells Fargo Securities, LLC designated by Account No. 1BC87871 shall contain (i) from April 26, 2023 through May 17, 2023, not less than $1,600,000.00 and (ii) at all times on and after May 18, 2023, not less than $1,075,000.00.”






4.Acknowledgements of Note Parties. Each of the Note Parties hereby acknowledges and agrees that: (i) the Existing Defaults have occurred and remain in effect as of the date hereof, (ii) Purchaser has not waived nor agreed to waive such Existing Defaults and has not agreed to any other restructuring, modification, amendment, waiver or forbearance except as expressly set forth in the Forbearance Agreement (iii) as of the close of business on the date hereof, the outstanding principal balance of the Note is not less than $2,294,522.44, plus accrued and unpaid interest, including Default Interest, of $19,503.44; (iv) because of the Existing Defaults, Purchaser is entitled to exercise all of its rights and remedies as Note holder, secured party and collateral agent, as applicable, under the Note Documents, including, without limitation, by accelerating and declaring the Note due and payable in full immediately for cash in an amount equal to the Event of Default Acceleration Amount pursuant to Section 11(B)(ii) of the Note in the amount of not less than $2,638,700.81, plus accrued and unpaid interest, including Default Interest; (v) the obligations of the Note Parties under the Note Documents include payment of all of Purchaser’s expenses, costs and fees, including attorneys’ fees, actually incurred in the enforcement of the Note Documents and drafting and negotiation of this Amendment.
5.Reaffirmation and Ratification of Note Documents, Liens and Security Interests. Each of the Note Parties hereby restates, ratifies, and reaffirms all of the terms and provisions of the Forbearance Agreement and the other Note Documents to which it is a party and agrees that such Note Documents are in full force and effect and shall continue to be valid and enforceable, without any counterclaim, defense or setoff, until the obligations are indefeasibly paid in full and all liabilities have been satisfied. Each of the Note Parties hereby restates, ratifies, and reaffirms that all obligations of the Note Parties to the Purchaser are secured by validly perfected, first priority security interests in and liens on substantially all personal property of the Note Parties, as provided in the Security Agreement, IP Security Agreement, Control Agreements, and related Note Documents, and that such liens and security interests are valid and subsisting against the property described in the Note Documents.
6.Conditions of Effectiveness of Amendment. This Amendment shall not be effective until the following conditions precedent have been satisfied or waived in writing:
(a)Purchaser shall have received counterparts of this Amendment executed by Issuer and Guarantor;
(b)No Default or Event of Default (other than the Existing Defaults) shall exist;
(c)The representations and warranties set forth in the Forbearance Agreement, the other Note Documents and herein shall be true and correct in all material respects, except (i) with respect to the existence of the Existing Defaults, (ii) to the extent already limited by materiality, in which case such representations and warranties shall be true and correct in all respects, and (iii) to the extent such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct as of such earlier date;

2



(d)Purchaser shall have received its costs and expenses, including out-of-pocket attorneys’ fees and expenses, in connection with the preparation, negotiation and execution of this Amendment;
(e)The Note Parties shall have made or caused to be made any filing and obtained any consent or authorization as necessary to execute, deliver and perform hereunder; and
(f)Purchaser shall have received such other documents, instruments and certificates as reasonably requested by Purchaser.
7.Representations and Warranties. Each of the Note Parties hereby represents, warrants and certifies that:
(a)The representations and warranties contained in the Forbearance Agreement and the other Note Documents to which it is a party are true and correct in all material respects on and as of the date hereof (except to the extent already limited by materiality, in which case such representations and warranties are true and correct in all respects), except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct as of such earlier date;
(b)this Amendment has been duly authorized, executed and delivered and constitutes a legal, valid and binding obligation of such Note Party in accordance with its terms; and
(c)other than the Existing Defaults, no Default or Event of Default exists.
8.Covenants.
(a)Issuer shall provide written notice to the Purchaser promptly upon the occurrence of any event or circumstance that may reasonably be expected to constitute or become a breach or Event of Default.
(b)No later than 9:15 a.m., New York time, on May 19, 2023, Issuer shall file a Current Report on Form 8-K (“Form 8-K”) disclosing all the material terms of the transactions contemplated by this Amendment. From and after the issuance of the Form 8-K, the Issuer and Guarantor shall have disclosed all material, non-public information (if any) provided to Purchaser by the Note Parties or any of their respective subsidiaries or any of their respective officers, directors, employees, or agents, and Purchaser shall not be in possession of any material, non-public information regarding the Issuer, Guarantor or any of their respective subsidiaries.
(c)The Note Parties shall take all such actions and execute and deliver all such documents and instruments as requested by Purchaser as necessary to give effect to the terms of this Amendment.

3



9.Continuing Effect of Forbearance Agreement. Except as expressly modified hereby as of the date hereof, the Forbearance Agreement remains in full force and effect in accordance with its terms.
10.Governing Law and Venue. This Amendment shall in all respects be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of any other jurisdiction.
11.Headings. Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.
12.Transaction Document. This Amendment is made a part of the Forbearance Agreement and is a Note Document and a Transaction Document (as defined in the SPA) and is subject to all provisions of the Note Documents applicable to Transaction Documents, all of which are incorporated in this Amendment by reference the same as if set forth in this Amendment verbatim.
13.Enforceability. Should any one or more of the provisions of this Amendment be determined to be illegal or unenforceable as to one or more of the Parties hereto, all other provisions nevertheless shall remain effective and binding on the Parties hereto.
14.Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of Issuer, Guarantor, Purchaser, and each of their respective successors and permitted assigns, provided that neither Issuer nor Guarantor may, without the prior written consent of Purchaser, assign any rights, powers, duties or obligations hereunder. Purchaser may sell, transfer, or assign any of its rights hereunder or under any of the Note Documents at any time without notice to or consent of Issuer or Guarantor, subject to the provisions of the Note Documents.
15.Waiver and Release. Each of the Note Parties warrants and represents to Purchaser that its obligations under the Note Documents are not subject to any credits, charges, claims, or rights of offset or deduction of any kind or character whatsoever and, as a material part of the consideration for Purchaser entering into this Amendment, each agrees as follows (the “Release Provision”):
(a)EACH OF THE NOTE PARTIES HEREBY RELEASES AND FOREVER DISCHARGES PURCHASER AND ITS PREDECESSORS, SUCCESSORS, ASSIGNS, OFFICERS, MANAGERS, DIRECTORS, MEMBERS, SHAREHOLDERS, EMPLOYEES, AGENTS, ATTORNEYS, REPRESENTATIVES, PARENT CORPORATIONS, SUBSIDIARIES, AND AFFILIATES (HEREINAFTER ALL OF THE ABOVE COLLECTIVELY REFERRED TO AS “RELEASED PARTIES”) JOINTLY AND SEVERALLY FROM ANY AND ALL CLAIMS, COUNTERCLAIMS, DEMANDS, DAMAGES, DEBTS, AGREEMENTS, COVENANTS, SUITS, CONTRACTS, OBLIGATIONS, LIABILITIES, ACCOUNTS, OFFSETS, RIGHTS, ACTIONS,

4



AND CAUSES OF ACTION OF ANY NATURE WHATSOEVER OCCURRING PRIOR TO THE DATE HEREOF, INCLUDING, WITHOUT LIMITATION, ALL CLAIMS, DEMANDS, AND CAUSES OF ACTION FOR CONTRIBUTION AND INDEMNITY, RE-CHARACTERIZATION, OR EQUITABLE SUBORDINATION, WHETHER ARISING AT LAW OR IN EQUITY, PRESENTLY POSSESSED, WHETHER KNOWN OR UNKNOWN, WHETHER LIABILITY BE DIRECT OR INDIRECT, LIQUIDATED OR UNLIQUIDATED, PRESENTLY ACCRUED, WHETHER ABSOLUTE OR CONTINGENT, FORESEEN OR UNFORESEEN, AND WHETHER OR NOT HERETOFORE ASSERTED (“CLAIMS”), WHICH EACH OF THE NOTE PARTIES MAY HAVE OR CLAIM TO HAVE AGAINST ANY OF THE RELEASED PARTIES.
(b)Each of the Note Parties agrees not to sue any of the Released Parties or in any way assist any other Person in suing any of the Released Parties with respect to any Claim released herein. The Release Provision may be pleaded as a full and complete defense to, and may be used as the basis for an injunction against, any action, suit, or other proceeding that may be instituted, prosecuted, or attempted in breach of the release contained herein.
(c)Each of the Note Parties acknowledges, warrants, and represents that it has read and understands the Release Provision and has had the assistance of independent counsel of its own choice in considering the terms of the Release Provision.
16.Returned Proceeds. Anything to the contrary herein notwithstanding, if any proceeds or property are remitted to Purchaser by or on behalf of any of the Note Parties in accordance with the terms hereof, and thereafter, as a result of the exercise of the authority of a trustee or debtor-in-possession under applicable provisions of the U.S. bankruptcy code, other insolvency law, or any provision of applicable federal or state law, Purchaser is required to, and does in fact, remit, rescind or restore the whole or any part of such proceeds or property (the “Returned Proceeds”), (a) the amount of any such Returned Proceeds shall be considered to have been unpaid at all times for the purposes of this Amendment, (b) the obligations of the Note Parties to Purchaser under the Note Documents (less the amount of Returned Proceeds paid and applied on account of the Note and not so returned), and the corresponding lien rights of Purchaser, shall be automatically reinstated nunc pro tunc, and (c) the Note Parties shall indemnify and hold Purchaser harmless from and against any and all losses and reasonable costs and expenses, including reasonable legal fees, incurred by Purchaser arising out of, relating to or in connection with such remittance, recission or restoration.
17.Amendments. This Amendment may not be amended except in a writing executed by Purchaser and all Parties hereto.
18.Counterparts. This Amendment may be executed in one or more counterparts, each of which shall be deemed an original (including electronic copies) but all of which together

5



shall constitute one and the same instrument. Electronic signatures hereto shall be effective as manually executed originals.
[Remainder of page intentionally left blank. Signature pages follow.]



6



IN WITNESS WHEREOF, the Issuer, Purchaser and Guarantor have caused this Agreement to be executed as of the day and year first above written.

ISSUER:

9 METERS BIOPHARMA, INC.,
A Delaware corporation


By:    /s/ Bethany Sensenig        
    Name: Bethany Sensenig    
    Title: Chief Financial Officer


GUARANTOR:

NAIA RARE DISEASES, LLC,
A Delaware limited liability corporation


By:    /s John Temperato        
    Name: John Temperato    
    Title: President







[SIGNATURES CONTINUE ON THE FOLLOWING PAGE]

[Signature Page to Amendment No. 1 to Forbearance Agreement]


PURCHASER:

HIGH TRAIL SPECIAL SITUATIONS LLC
A Delaware limited liability company


By:    /s/ Eric Helenek        
    Name: Eric Helenek
                         Title: Authorized Signatory

[Signature Page to Amendment No. 1 to Forbearance Agreement]
EX-101.SCH 3 nmtr-20230518.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 nmtr-20230518_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 nmtr-20230518_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, Address Line Two Entity Address, Address Line Two Entity Central Index Key Entity Central Index Key Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Soliciting Material Soliciting Material Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Address Type [Domain] Address Type [Domain] City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Addresses [Line Items] Entity Addresses [Line Items] Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Entity Tax Identification Number Entity Tax Identification Number Entity Addresses [Table] Entity Addresses [Table] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, City or Town Entity Address, City or Town Former Address Former Address [Member] Local Phone Number Local Phone Number Written Communications Written Communications Cover [Abstract] Document Type Document Type Entity Address, State or Province Entity Address, State or Province Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 6 nmtr-20230518_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
May 18, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 18, 2023
Entity Registrant Name 9 Meters Biopharma, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-37797
Entity Tax Identification Number 27-3948465
City Area Code 919
Local Phone Number 275-1933
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock $0.0001 Par Value
Trading Symbol NMTR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001551986
Amendment Flag false
Entity Addresses [Line Items]  
Entity Address, Address Line One 4509 Creedmoor Road
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Raleigh
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27612
XML 8 nmtr-20230518_htm.xml IDEA: XBRL DOCUMENT 0001551986 2023-05-18 2023-05-18 0001551986 false 8-K 2023-05-18 9 Meters Biopharma, Inc. DE 001-37797 27-3948465 4509 Creedmoor Road Suite 600 Raleigh NC 27612 919 275-1933 false false false false Common Stock $0.0001 Par Value NMTR NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:G%C:^?VZH:TE[VE-S9NMQ=%A?B MTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!Q+MTFF6SU%L, M9KD8M;:X1+_)UW,#ECQ ,ZE._<]'<')O$8T.,5RMQD)HDU M75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6J6"%'*7?Z/6M M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5%1:PIJ+U$&3H MD<%U!D.LL8DF"=9#;E9T!N[RZ .;O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0 ( %U LU8D M'INBK0 /@! : >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T. M@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4 M=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[N MF:*'3^ 5!+ P04 " != M0+-699!YDAD! #/ P $P %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0 MA:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS> MCQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[ ME.O5,[1R;ZEXZ7D;3?!-FI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8: M8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X M(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA M/UY_ 5!+ 0(4 Q0 ( %U LU8'04UB@0 +$ 0 " M 0 !D;V-0&UL4$L! A0#% @ 74"S5E;-A#_O M*P( !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! A0# M% @ 74"S5IE&PO=V]R:W-H965T&UL4$L! A0# M% @ 74"S5I^@&_"Q @ X@P T ( !N@P 'AL+W-T M>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% M @ 74"S5B0>FZ*M ^ $ !H ( !WQ$ 'AL+U]R96QS M+W=O9(9 0 SP, M !, ( !Q!( %M#;VYT96YT7U1Y<&5S72YX;6Q02P4& / D "0 ^ @ #A0 end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://9meters.com/role/Cover Cover Cover 1 false false All Reports Book All Reports nmtr-20230518.htm ex-101forbearanceagmt523.htm nmtr-20230518.xsd nmtr-20230518_def.xml nmtr-20230518_lab.xml nmtr-20230518_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nmtr-20230518.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "definitionLink": { "local": [ "nmtr-20230518_def.xml" ] }, "inline": { "local": [ "nmtr-20230518.htm" ] }, "labelLink": { "local": [ "nmtr-20230518_lab.xml" ] }, "presentationLink": { "local": [ "nmtr-20230518_pre.xml" ] }, "schema": { "local": [ "nmtr-20230518.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nmtr", "nsuri": "http://9meters.com/20230518", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nmtr-20230518.htm", "contextRef": "ib2298971af9744f7a80512761e59c575_D20230518-20230518", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://9meters.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nmtr-20230518.htm", "contextRef": "ib2298971af9744f7a80512761e59c575_D20230518-20230518", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]", "terseLabel": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]", "terseLabel": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]", "terseLabel": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]", "terseLabel": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_FormerAddressMember": { "auth_ref": [ "r6", "r7" ], "lang": { "en-us": { "role": { "documentation": "Former address for entity", "label": "Former Address [Member]", "terseLabel": "Former Address" } } }, "localname": "FormerAddressMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://9meters.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Form 10-Q", "Number": "249", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Form 8-K", "Number": "249", "Publisher": "SEC", "Section": "308", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001551986-23-000041-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001551986-23-000041-xbrl.zip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end